BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  iTeos Reports First Quarter 2022 Financial Results and Provides Business Update

  iTeos Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2022 and provided recent corporate highlights.

  May 12, 2022

   · 

  11 min read
• Business

  Landos Biopharma Reports First Quarter 2022 Results and Provides Business Update

  Landos Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, announced financial results for the first quarter ended March 31, 2022, and provided a business update.

  May 12, 2022

   · 

  7 min read
• Business

  Bellicum Reports First Quarter 2022 Financial Results and Provides Operational Update

  Bellicum Pharmaceuticals, Inc. reported financial results for the first quarter 2022 and provided an operational update.

  May 12, 2022

   · 

  5 min read
• Business

  4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates

  4D Molecular Therapeutics, Inc. reported first quarter 2022 financial results and provided corporate updates.

  May 12, 2022

   · 

  9 min read
• Business

  VYNE Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

  VYNE Therapeutics Inc. announced financial results for the quarter ended March 31, 2022 and provided a business update.

  May 12, 2022

   · 

  21 min read
• Business

  Actym Therapeutics Announces Significant Expansion of Senior Leadership

  Actym Therapeutics announced the significant expansion of its senior leadership team.

  May 12, 2022

   · 

  5 min read
• Pharm Country

  Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio

  Sandoz announced the US launch of its generic pirfenidone, the first AB-rated equivalent to Genentech’s Esbriet®*, to treat patients with idiopathic pulmonary fibrosis.

  May 12, 2022

   · 

  11 min read
• Business

  Arcellx Provides Business Updates and Reports First Quarter 2022 Financial Results

  Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported business highlights and financial results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  9 min read
• Business

  Co-Diagnostics Reports Solid First Quarter 2022 Financial Results

  Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  9 min read
• Business

  NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

  NeuroOne Medical Technologies Corporation announces its operating results for the second quarter of fiscal year 2022 ended March 31, 2022.

  May 12, 2022

   · 

  9 min read